deferoxamine has been researched along with oxalates in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, F; Kaneko, M; Kodama, M | 1 |
| Cervini-Silva, J; Sposito, G | 1 |
| DANIEL, EE; IRWIN, J | 1 |
| Balatoni, JA; González-Lepera, C; Lin, M; Mukhopadhyay, U; Waligorski, GJ | 1 |
| Bouziotis, P; Eisenhut, M; Filosofov, D; Harris, AL; Hauser, H; la Fuente, Ad; Loudos, G; Paravatou-Petsotas, M; Ponsard, B; Radchenko, V; Roesch, F; Tsotakos, T; Xanthopoulos, S | 1 |
| Bubenshchikov, V; Larenkov, A; Makichyan, A | 1 |
6 other study(ies) available for deferoxamine and oxalates
| Article | Year |
|---|---|
The localization of DMPO spin adducts of OH in endothelial cells exposed to hydrogen peroxide.
Topics: Animals; Antidotes; Aorta; Cattle; Cyclic N-Oxides; Deferoxamine; Electron Spin Resonance Spectroscopy; Endothelium, Vascular; Free Radical Scavengers; Hydrogen Peroxide; Iron Chelating Agents; Oxalates; Oxidants; Polyethylene Glycols; Spin Labels | 1995 |
Steady-state dissolution kinetics of aluminum-goethite in the presence of desferrioxamine-B and oxalate ligands.
Topics: Aluminum; Deferoxamine; Hydrogen-Ion Concentration; Iron Chelating Agents; Iron Compounds; Kinetics; Ligands; Minerals; Oxalates; Solubility | 2002 |
ON THE MECHANISMS WHEREBY EDTA, EGTA, DPTA, OXALATE, DESFERRIOXAMINE, AND 1,10-PHENANTHROLINE AFFECT CONTRACTILITY OF RAT UTERUS.
Topics: Calcium; Chelating Agents; Deferoxamine; Edetic Acid; Egtazic Acid; Female; Humans; Magnesium; Muscle Contraction; Muscle, Smooth; Oxalates; Pharmacology; Phenanthrolines; Rats; Research; Sodium; Strontium; Uterus | 1965 |
Semi-automated production of ⁸⁹Zr-oxalate/⁸⁹Zr-chloride and the potential of ⁸⁹Zr-chloride in radiopharmaceutical compounding.
Topics: Chemistry, Pharmaceutical; Chlorides; Cyclotrons; Deferoxamine; Humans; Immunoglobulin G; Isotope Labeling; Oxalates; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Solid Phase Extraction; Zirconium | 2016 |
Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study.
Topics: Animals; Bevacizumab; Chlorides; Deferoxamine; Drug Stability; Female; Half-Life; Isotope Labeling; Mice; Niobium; Oxalates; Positron-Emission Tomography; Radioisotopes; Tissue Distribution | 2016 |
The impact of zirconium-89 solution formulation on the efficiency of [
Topics: Chlorides; Citrates; Deferoxamine; Oxalates; Positron-Emission Tomography; Zirconium | 2022 |